SMM News: us Eastern time on Tuesday, driven by the elimination of uncertainty in the US general election, good vaccine, global central bank easing policy and other factors, the global market ushered in a carnival before Thanksgiving.
The three major stock indexes in the United States rose across the board, and the Dow hit a new high, breaking 30,000 points for the first time in history. As of press time, all three major u.s. stock indexes are up more than 1%. Major European stock indexes all closed up more than 1%.
International oil prices hit their highest level since March on Tuesday, with WTI crude futures breaking through the $45 mark and Brent futures approaching the $48 mark, which is still up more than 3 per cent as of press time.
Driven by rising oil prices, energy stocks soared on Tuesday, with the energy sector up more than 4 per cent, making it the best performer in the s & p 500, with Chevron up more than 4 per cent and ExxonMobil up more than 5 per cent.
Gold futures fell below the $1800 mark on Tuesday and are still down more than 2 per cent as of press time due to a sharp rise in global risk appetite.
In addition to the fundamental positive of global central bank easing, the global market has recently ushered in a series of positive news. After trading on Monday, the US General Affairs Office informed Biden that the transfer of power process officially began, the uncertainty of the US general election was basically cleared away, and Wall Street expected the multilateralism of the Biden administration to benefit the market.
Biden's nomination of Yellen as US Treasury Secretary also boosted market sentiment. Yellen was seen by many as a "market-friendly" choice. Yellen kept interest rates low for a long time as chairman of the Federal Reserve, boosting long-term economic growth. Yellen is expected to push for further fiscal stimulus measures to help the economy.
In addition, recently, the global vaccine has been widely spread. Europe and the United States have ushered in three "effective vaccines". Both Pfizer and Moderna have an effective rate of more than 90%. Although the average effective rate of AstraZeneca vaccine is slightly lower, it does not require high storage conditions and the price is cheaper.
But the epidemic remains a risk that cannot be ignored, and investors are weighing the vaccine against a rebound in the epidemic, a swing that has dominated the market recently. As the epidemic worsens in the United States, Goldman Sachs and mo Chase have downgraded their near-term economic prospects, and the global economy will have to go through a painful period before vaccines are widely available.
